isatin - CISMeF

Preferred Label : isatin;

MeSH definition : An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients.;

MeSH synonym : 2,3-dioxoindoline; 2,3 dioxoindoline;

MeSH CAS label : 1H-Indole-2,3-dione;

MeSH Related Number : 91-56-5 (Isatin);

Registry Number MeSH : 91-56-5;

MeSH annotation : do not confuse with isatan;

Wikipedia link : https://en.wikipedia.org/wiki/Isatin;

Codes EINECS : 202-077-8;

Is substance : O;

UNII : 82X95S7M06;

InChIKey : JXDYKVIHCLTXOP-UHFFFAOYSA-N;

Details

Origin ID

D007510;

UMLS CUI

C0022115;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- isatin [Substance BNPC]
Record concept(s)
- isatin [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((2-hydroxy-1-naphthaldehyde)-3-isatin)-bishydrazone [MeSH Supplementary Concept]
- 1-((2-methylbenzimidazol-1-yl)methyl)-2-oxoindolin-3-ylidene)amino)thiourea [MeSH Supplementary Concept]
- 1-(4-(2-fluoroethoxy)benzyl)-5-(1-(2-methoxymethylpyrrolidinyl)sulfonyl)isatin [MeSH Supplementary Concept]
- 1-acetylisatin [MeSH Supplementary Concept]
- 1-ethylisatin-S-n-butylisothiosemicarbazone [MeSH Supplementary Concept]
- 1-methyl-3-(1-hexynyl)-3-hydroxy-2-indolinone [MeSH Supplementary Concept]
- 1-methylisatin 3-semicarbazone [MeSH Supplementary Concept]
- 1-morpholinomethyl-5-methylisatin [MeSH Supplementary Concept]
- 13-deoxy-isatisine A [MeSH Supplementary Concept]
- 2,2'-pyridylisatogen [MeSH Supplementary Concept]
- 2,2'-pyridylisatogen tosylate [MeSH Supplementary Concept]
- 2-phenylisatogen [MeSH Supplementary Concept]
- 3-(1-hexynyl)-3-hydroxy-2-indolinone [MeSH Supplementary Concept]
- 3-(1-hexynyl)-3-hydroxy-5-nitro-2-indolinone [MeSH Supplementary Concept]
- 4-(2-(2-(2-oxoindolin-3-ylidene)hydrazinyl)thiazol-4-yl)benzonitrile [MeSH Supplementary Concept]
- 5,7-dibromo-N-(4-methylbenzyl)isatin [MeSH Supplementary Concept]
- 5-(1-(2-methoxymethylpyrrolidinyl)sulfonyl)isatin [MeSH Supplementary Concept]
- 5-aminoisatin [MeSH Supplementary Concept]
- 5-bromoisatin [MeSH Supplementary Concept]
- 5-butylisatin [MeSH Supplementary Concept]
- 5-chloro-1-(1-(3-(7-chloroquinolin-4-ylamino)propyl)-1H-(1,2,3)triazol-4-ylmethyl)-1H-indole-2,3-dione [MeSH Supplementary Concept]
- 5-hydroxyisatin [MeSH Supplementary Concept]
- 5-iodoisatin [MeSH Supplementary Concept]
- 5-methylisatin [MeSH Supplementary Concept]
- 6-(3'-methylbuten-2'-yl)isatin [MeSH Supplementary Concept]
- 6-bromoisatin [MeSH Supplementary Concept]
- 7-prenylisatin [MeSH Supplementary Concept]
- 7-trifluoromethylisatin [MeSH Supplementary Concept]
- LJNK compound [MeSH Supplementary Concept]
- ML 137 [MeSH Supplementary Concept]
- N-(3-fluoro-4-hydroxybutyl)-5-(1-(2-(methoxymethyl)pyrrolidinyl)sulfonyl)isatin [MeSH Supplementary Concept]
- N-(4-fluoro-3-hydroxybutyl)-5-(1-(2-(methoxymethyl)pyrrolidinyl)sulfonyl)isatin [MeSH Supplementary Concept]
- N-4-chlorobenzoylisatinic acid [MeSH Supplementary Concept]
- N-allylisatin-beta-4',4'-diallylthiosemicarbazone [MeSH Supplementary Concept]
- N-benzoylisatinic acid [MeSH Supplementary Concept]
- N-benzylisatin [MeSH Supplementary Concept]
- N-ethylisatin-beta-thiosemicarbazone [MeSH Supplementary Concept]
- N-methylisatin 3-picolinoyl hydrazone [MeSH Supplementary Concept]
- VU 01119498 [MeSH Supplementary Concept]
- WC-4-116 [MeSH Supplementary Concept]
- convolutamydine A [MeSH Supplementary Concept]
- convolutamydine B [MeSH Supplementary Concept]
- convolutamydine E [MeSH Supplementary Concept]
- isatin 3-picolinoyl hydrazone [MeSH Supplementary Concept]
- isatin 3-semicarbazone [MeSH Supplementary Concept]
- isatin beta-thiosemicarbazone [MeSH Supplementary Concept]
- isatin isothiosemicarbazone [MeSH Supplementary Concept]
- isatin-3-isonicotinylhydrazone [MeSH Supplementary Concept]
- isatin-3-oxime [MeSH Supplementary Concept]
- isatin-3-oxime-glucoside [MeSH Supplementary Concept]
- isatin-5-sulfonic acid [MeSH Supplementary Concept]
- isatisine A [MeSH Supplementary Concept]
- isatogen [MeSH Supplementary Concept]
- laxagetten 4,4'-diacetoxydiphenylpyridylemethane [MeSH Supplementary Concept]
- methyl 3-(1-(4-methoxybenzyl)-2,3-dioxoindolin-5-yl)acrylate [MeSH Supplementary Concept]
- propargylic sulfone [MeSH Supplementary Concept]
- tribulin [MeSH Supplementary Concept]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- isatin [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients